ArticleAmerican journal of physiology. Renal physiology2008

Rosiglitazone reduces renal and plasma markers of oxidative injury and reverses urinary metabolite abnormalities in the amelioration of diabetic nephropathy.

Hongyu Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.